相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Predictors of non-adherence to aromatase inhibitors among commercially insured women with breast cancer
Rebecca L. Sedjo et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer
Dawn L. Hershman et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Prevention and treatment of side-effects of systemic treatment: bone loss
J. -J. Body
ANNALS OF ONCOLOGY (2010)
Aromatase inhibitors versus tamoxifen as adjuvant therapy for postmenopausal women with estrogen receptor positive breast cancer: meta-analyses of randomized trials of monotherapy and switching strategies.
JN Ingle et al.
CANCER RESEARCH (2010)
Oncologists' Recommendations for Adjuvant Therapy in Hormone Receptor-Positive Breast Cancer Patients of Varying Age and Health Status
Arash Naeim et al.
CLINICAL BREAST CANCER (2010)
Improving compliance and persistence to adjuvant tamoxifen and aromatase inhibitor therapy
Peyman Hadji
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2010)
Effects of Toremifene and Tamoxifen on Lipid Profiles in Post-menopausal Patients with Early Breast Cancer: Interim Results from a Japanese Phase III Trial
Takeshi Tominaga et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2010)
Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer
V. Ziller et al.
ANNALS OF ONCOLOGY (2009)
Patient Adherence and Persistence With Oral Anticancer Treatment
Kathryn Ruddy et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2009)
Cancer Treatment Adherence Among Low-Income Women With Breast or Gynecologic Cancer
Kathleen Ell et al.
CANCER (2009)
A review of interventions used to improve adherence to medication in older people
Maggi Banning
INTERNATIONAL JOURNAL OF NURSING STUDIES (2009)
Target and reality of adjuvant endocrine therapy in postmenopausal patients with invasive breast cancer
U. Gueth et al.
BRITISH JOURNAL OF CANCER (2008)
Risk of early recurrence among postmenopausal women with estrogen receptor-positive early breast cancer treated with adjuvant tamoxifen
Hagen Kennecke et al.
CANCER (2008)
Choosing early adjuvant therapy for postmenopausal women with hormone-sensitive breast cancer: Aromatase inhibitors versus tamoxifen
R. Carpenter
EJSO (2008)
Aromatase inhibitors for breast cancer: different structures, same effects?
Riccardo Ponzone et al.
ENDOCRINE-RELATED CANCER (2008)
Lifestyle habits as a contributor to anti-cancer treatment failure
Floris A. de Jong et al.
EUROPEAN JOURNAL OF CANCER (2008)
Older people and adherence with medication: A review of the literature
Maggi Banning
INTERNATIONAL JOURNAL OF NURSING STUDIES (2008)
Predictors of tamoxifen discontinuation among older women with estrogen receptor-positive breast cancer
Cynthia Owusu et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer
Ann H. Partridge et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Aromatase inhibitors: A new reality for the adjuvant endocrine treatment of early-stage breast cancer in postmenopausal women
M. Colozza et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2008)
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial
Norman Williams
LANCET ONCOLOGY (2008)
Reducing the risk for breast cancer recurrence after completion of tamoxifen treatment in postmenopausal women
Mohammad Jahanzeb
CLINICAL THERAPEUTICS (2007)
Prescription drug cost sharing associations with medication and medical utilization and spending and health
Dana P. Goldman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer:: Update of study BIG 1-98
Alan S. Coates et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Quality of life of postmenopausal women in the ATAC (Arimidex, tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment for early breast cancer
David Cella et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Intentional and non-intentional non-adherence to medication amongst breast cancer patients
Louise Atkins et al.
EUROPEAN JOURNAL OF CANCER (2006)
Adherence to tamoxifen over the five-year course
Timothy L. Lash et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Adherence beliefs among breast cancer patients taking tamoxifen
EA Grunfeld et al.
PATIENT EDUCATION AND COUNSELING (2005)
Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: Updated findings from NCICCTG MA.17
PE Goss et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial
R Jakesz et al.
LANCET (2005)
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
American Society of Clinical Oncology Technology Assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: Status report 2004
EP Winer et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer
RC Coombes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Patient beliefs and tamoxifen discontinuance in older women with estrogen receptor-positive breast cancer
AK Fink et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer
AH Partridge et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Adjuvant tamoxifen prescription in women 65 years and older with primary breast cancer
RA Silliman et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
分享论文
